dabigatran etexilate 150 MG Oral Capsule [Pradaxa]
RxNorm concept 1037049, branded drug (sbd). Prescribable name: Pradaxa 150 MG Oral Capsule.
- RxCUI
- 1037049
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1037049 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pradaxa 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Capsule; Pradaxa 150 MG Oral Capsule
Related concepts
- dabigatran etexilate 150 MG (SCDC, consists of)
- dabigatran etexilate 150 MG [Pradaxa] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Pradaxa (BN, has ingredient)
- dabigatran etexilate 150 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 00597036042
- 00597036055
- 00597036082
- 50090448000
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1037049 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1037049 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1037049. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.